Pharmaceutical / Drug Definition :
Inhibits action of acetylcholine on muscarinic receptors that mediate effects of parasympathetic postganglionic impulses. This inhibition relaxes cardiac smooth muscle, inhibits vagal reflexes, and decreases tracheal and bronchial secretions.
In the United States, Glycopyrrolate is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Glycopyrrolate.
FDA Label Requirements and Exceptions
FDA Import Information
Glycopyrrolate (Glycopyrrolate Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Glycopyrrolate (Glycopyrrolate Suppliers)
- Processors Glycopyrrolate
- Repackers Glycopyrrolate
- Relabelers Glycopyrrolate
- Exporters Glycopyrrolate
- Importers Glycopyrrolate
For more information about Glycopyrrolate, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.